Current nonclinical in vivo safety pharmacology testing enables safe entry to first-in-human clinical trials: The IQ consortium nonclinical to clinical translational database

Autor:	Matthew M. Abernathy, Malar Pannirselvam, Alysia A. Chaves, Annie Delaunois, Michael C. Foley, Jonathan Maher, Jean-Michel Guillon, Tom Monticello, Hugo M. Vargas, Bruce Damiano, Andrea Greiter-Wilke, Jon Renninger, David C. Ackley
Rok vydání:	2019
Předmět:	Pharmacology Clinical trial medicine.medical_specialty In vivo business.industry Safety pharmacology MEDLINE medicine Medical physics First in human Toxicology business
Zdroj:	Journal of Pharmacological and Toxicological Methods. 99:106595
ISSN:	1056-8719
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f751d1386126863b350f79c2070e221a https://doi.org/10.1016/j.vascn.2019.05.152 Zobrazit plný text záznamu Full Text from ScienceDirect